JAAD Case Reports

1.2(top 50%)

impact factor

2.8K(top 10%)

papers

11.7K(top 20%)

citations

32(top 20%)

h-index

1.2(top 50%)

impact factor

3.4K

all documents

13.0K

doc citations

46(top 20%)

g-index

Top Articles

#	Title	Journal	Year	Citations
1	Coronavirus (COVID-19) infection–induced chilblains: A case report with histopathologic findings	JAAD Case Reports	2020	215
2	Varicella-zoster virus reactivation after SARS-CoV-2 BNT162b2 mRNA vaccination: Report of 5 cases	JAAD Case Reports	2021	87
3	Immune-related sarcoidosis observed in combination ipilimumab and nivolumab therapy	JAAD Case Reports	2016	86
4	Pembrolizumab-associated sarcoidosis	JAAD Case Reports	2016	80
5	Nivolumab-related cutaneous sarcoidosis in a patient with lung adenocarcinoma	JAAD Case Reports	2017	67
6	Oral angiotensin-converting enzyme inhibitors for treatment of delayed inflammatory reaction to dermal hyaluronic acid fillers following COVID-19 vaccination-a model for inhibition of angiotensin II–induced cutaneous inflammation	JAAD Case Reports	2021	65
7	Development of bullous pemphigoid during nivolumab therapy	JAAD Case Reports	2016	60
8	Morbilliform exanthem associated with COVID-19	JAAD Case Reports	2020	58
9	Introduction to reflectance confocal microscopy and its use in clinical practice	JAAD Case Reports	2018	57
10	Alopecia areata after dupilumab for atopic dermatitis	JAAD Case Reports	2018	56
11	Treatment of generalized deep morphea and eosinophilic fasciitis with the Janus kinase inhibitor tofacitinib	JAAD Case Reports	2018	52
12	Erythrodermic presentation of psoriasis in a patient treated with dupilumab	JAAD Case Reports	2018	52
13	Resolution of cutaneous sarcoidosis after Janus kinase inhibitor therapy for concomitant polycythemia vera	JAAD Case Reports	2019	51
14	Nivolumab-associated vitiligo-like depigmentation in a patient with acute myeloid leukemia: A novel finding	JAAD Case Reports	2017	50
15	“COVID arm”: A reaction to the Moderna vaccine	JAAD Case Reports	2021	49
16	Infliximab therapy for Netherton syndrome: A case report	JAAD Case Reports	2017	47
17	Drug-induced alopecia after dupilumab therapy	JAAD Case Reports	2019	46
18	The role of expanded series patch testing in identifying causality of residual facial dermatitis following initiation of dupilumab therapy	JAAD Case Reports	2018	45
19	Treatment of monilethrix with oral minoxidil	JAAD Case Reports	2016	44
20	Dupilumab facial redness: Positive effect of itraconazole	JAAD Case Reports	2019	42
21	Urticarial exanthem as early diagnostic clue for COVID-19 infection	JAAD Case Reports	2020	42
22	Toxic epidermal necrolysis (TEN) associated with the use of nivolumab (PD-1 inhibitor) for lymphoma	JAAD Case Reports	2018	41
23	A case of severe cutaneous adverse reaction following administration of the Janssen Ad26.COV2.S COVID-19 vaccine	JAAD Case Reports	2021	41
24	Complete pathologic response of metastatic cutaneous squamous cell carcinoma and allograft rejection after treatment with combination immune checkpoint blockade	JAAD Case Reports	2017	40
25	Recalcitrant prurigo nodularis treated successfully with dupilumab	JAAD Case Reports	2019	39
26	Tofacitinib shows benefit in conjunction with other therapies in recalcitrant hidradenitis suppurativa patients	JAAD Case Reports	2020	39
27	Herpes zoster and severe acute herpetic neuralgia as a complication of COVID-19 infection	JAAD Case Reports	2020	39
28	A case of metastatic basal cell carcinoma treated with continuous PD-1 inhibitor exposure even after subsequent initiation of radiotherapy and surgery	JAAD Case Reports	2018	37
29	Sarcoid-like reaction in a patient recovering from coronavirus disease 19 pneumonia	JAAD Case Reports	2020	37
30	Acute generalized pustular psoriasis exacerbated by the COVID-19 vaccine	JAAD Case Reports	2021	37
31	Increasing evidence for omalizumab in the treatment of bullous pemphigoid	JAAD Case Reports	2020	36
32	Dupilumab-induced phenotype switching from atopic dermatitis to psoriasis	JAAD Case Reports	2020	36
33	Successful treatment of corticosteroid-resistant ophiasis-type alopecia areata (AA) with platelet-rich plasma (PRP)	JAAD Case Reports	2015	35
34	Alopecia areata after SARS-CoV-2 vaccination	JAAD Case Reports	2022	35
35	Nivolumab-associated DRESS syndrome: A case report	JAAD Case Reports	2019	34
36	Incidental regression of an advanced basal cell carcinoma after ipilimumab exposure for metastatic melanoma	JAAD Case Reports	2016	33
37	Pityriasis rosea and pityriasis rosea-like eruptions: How to distinguish them?	JAAD Case Reports	2018	33
38	Secukinumab and hidradenitis suppurativa: Friends or foes?	JAAD Case Reports	2019	33
39	Janus kinase inhibition in Down syndrome: 2 cases of therapeutic benefit for alopecia areata	JAAD Case Reports	2019	33
40	Dupilumab for the treatment of severe atopic dermatitis in a pregnant patient: A case report	JAAD Case Reports	2020	33
41	Tocilizumab for treatment of cutaneous and systemic manifestations of vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic (VEXAS) syndrome without myelodysplastic syndrome	JAAD Case Reports	2022	33
42	Successful use of ustekinumab therapy in refractory severe atopic dermatitis	JAAD Case Reports	2015	32
43	Severe, ulcerative, lichenoid mucositis associated with secukinumab	JAAD Case Reports	2016	32
44	Talimogene laherparepvec for regionally advanced Merkel cell carcinoma: A report of 2 cases	JAAD Case Reports	2017	31
45	Acceleration of cutaneous T-cell lymphoma following dupilumab administration	JAAD Case Reports	2021	31
46	Ustekinumab-induced subacute cutaneous lupus	JAAD Case Reports	2019	30
47	Remission of alopecia universalis in a patient with atopic dermatitis treated with dupilumab	JAAD Case Reports	2019	28
48	Lifitegrast add-on treatment for dupilumab-induced ocular surface disease (DIOSD): A novel case report	JAAD Case Reports	2019	28
49	Treatment-resistant dermatophytosis: A representative case highlighting an emerging public health threat	JAAD Case Reports	2020	28
50	Hair regrowth in 2 patients with recalcitrant central centrifugal cicatricial alopecia after use of topical metformin	JAAD Case Reports	2020	28

Scientometrics

Overviews

Citing Bodies

JAAD Case Reports

Top Articles